Milvexian vs apixaban for stroke prevention in atrial fibrillation: The LIBREXIA atrial fibrillation trial rationale and design

Authors

Institutions

Publication Details

Journal
American Heart Journal
Published
2024-08-29
DOI
https://doi.org/10.1016/j.ahj.2024.08.011
Citations
25
Primary Topic
Atrial Fibrillation Management and Outcomes
Type
article
Field-Weighted Citation Impact
10.05

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Milvexian vs apixaban for stroke prevention in atrial fibrillation: The LIBREXIA atrial fibrillation trial rationale and design

S. Claiborne Johnston, Philippe Gabríel Steg, Basil S. Lewis, Wataru Shimizu et al.
25 citations
American Heart Journal
Atrial Fibrillation Management and Outcomes
10.05
article

Milvexian vs apixaban for stroke prevention in atrial fibrillation: The LIBREXIA atrial fibrillation trial rationale and design

S. Claiborne Johnston, Philippe Gabríel Steg, Basil S. Lewis, Wataru Shimizu, Jay Horrow, Karen S. Pieper, Graeme J. Hankey, Roxana Mehran, Stephen Weng, Christian T. Ruff, Jan H. Cornel, Sneha S. Jain, Kenneth W. Mahaffey, Julia Donahue, Robert A. Harrington, Danshi Li, Hooman Kamel, Carolyn S.P. Lam, Tatjana Potpara, John Strony, Jeffrey Ian Weitz, C. Michael Gibson, Alexei N. Plotnikov, Peter R. Kowey
article en
25 citations

Abstract

No abstract available for this paper.
American Heart JournalVol. 277
Brigham and Women's Hospital (US), Johnson & Johnson (United States) (US), Harvard University (US), Janssen (Belgium) (BE), Radboud University Nijmegen (NL), Thomas Jefferson University (US), National University of Singapore (SG), Technion – Israel Institute of Technology (IL), The University of Western Australia (AU), University of California, San Francisco (US), Lankenau Institute for Medical Research (US), Université Paris Cité (FR), Cornell University (US), Cardiovascular Institute of the South (US), University Medical Center (US), Radboud University Medical Center (NL), University of Belgrade (RS), Noordwest Ziekenhuisgroep (NL), Bristol-Myers Squibb (United States) (US), Assistance Publique – Hôpitaux de Paris (FR), MIND Research Institute (US), National University Heart Centre Singapore (SG), Baim Institute for Clinical Research (US), Centar za Promociju Nauke (RS), Carmel Medical Center (IL), Stanford Medicine (US), Thrombosis Research Institute (GB), Perron Institute for Neurological and Translational Science (AU), National Heart Centre Singapore (SG), Janssen (United States) (US), Center for Clinical Research (United States) (US), Nippon Medical School (JP), Stanford University (US), McMaster University (CA), Icahn School of Medicine at Mount Sinai (US)
Bristol-Myers Squibb, Janssen Research and Development
Good health and well-being
Openalex Percentile: Top 1%
Atrial Fibrillation Management and Outcomes
10.05
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.